Form 4: Legend Biotech CEO Receives Stock Grant
Insider Transaction (Form 4)
Ingrid Zhang, Chief Executive Officer of Legend Biotech Corp, received 1,131,860 shares of common stock on September 15, 2026.
Summary
- Grant/award: acquired 1,131,860 Ordinary Shares on September 15, 2026; holds 1,131,860 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ingrid Zhang — Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Grant/award | Ordinary Shares | 1,131,860 | — | — | 1,131,860 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Grant/award (1,131,860 shares) |
Keywords
insider transaction, Form 4, LEGN, Legend Biotech Corp, neutral, Ingrid Zhang
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.